Gut micribiota modulates apoptosis of cisplatin in mouse model of ovarian cancer
Source: CNGBdb Project (ID CNP0004558)
CC BY 4

0 0

Description: 6-8-week-old ID8-bearing mice were divided into three groups: the OC group, the cisplatin group, and the cisplatin+ABX group. The cisplatin group was administered cisplatin (5mg/kg) intraperitoneally every 5 days for 3 times after tumor confirmation. The cisplatin+ABX group received an antibiotic cocktail for 5 consecutive days before tumor cell implantation, and antibiotic treatment was continued every 3 days until the completion of the experiment. Cisplatin treatment was administered in the cisplatin+ABX group as in the cisplatin group. The OC group served as the control. Two weeks after cisplatin treatment initiation, all mice were sacrificed, and tumor tissue were collected. The tumor tissue of the cisplatin group and cisplatin+ABX group were for RNA sequencing.
Data type: Raw sequence reads
Sample scope: Multiisolate
Relevance: Medical
Submitter: 麦振声(Zhensheng Mai); 佛山市第一人民医院
Release date: 2024-05-21
Last updated: 2024-05-21
Statistics: 8 samples; 8 experiments; 8 runs
Data size: 48.23GB